JS

Jay Copeland Strum

GT G1 Therapeutics: 41 patents #1 of 31Top 4%
GT Gi Therapeutics: 6 patents #1 of 12Top 9%
PA Pharmacosmos Holding A/S: 3 patents #6 of 20Top 30%
Harvard University: 1 patents #1,740 of 3,600Top 50%
BH Brigham and Women's Hospital: 1 patents #847 of 1,764Top 50%
UH University Of North Carolina At Chapel Hill: 1 patents #769 of 1,688Top 50%
📍 Hillsborough, NC: #1 of 252 inventorsTop 1%
🗺 North Carolina: #545 of 45,564 inventorsTop 2%
Overall (All Time): #51,888 of 4,157,543Top 2%
51
Patents All Time

Issued Patents All Time

Showing 26–50 of 51 patents

Patent #TitleCo-InventorsDate
10618905 Pyrimidine-based compounds for the treatment of cancer 2020-04-14
10434104 HSPC-sparing treatments for Rb-positive abnormal cellular proliferation John Emerson Bisi, Patrick Joseph Roberts, Francis Xavier Tavares 2019-10-08
10413547 Treatment of Rb-negative tumors using topoisomerase with cyclin dependent kinase 4/6 inhibitors John Emerson Bisi, Patrick Joseph Roberts, Jessica A. Sorrentino 2019-09-17
10376519 Tricyclic lactams for use in HSPC-sparing treatments for Rb-positive abnormal cellular proliferation John Emerson Bisi, Patrick Joseph Roberts, Ricky D. Gaston, Robert C. Gadwood 2019-08-13
10231969 Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat RB-positive tumors John Emerson Bisi, Patrick Joseph Roberts, Jessica A. Sorrentino, Hannah S. White 2019-03-19
10208011 Benzothiophene estrogen receptor modulators 2019-02-19
10189849 CDK inhibitors Francis Xavier Tavares 2019-01-29
10189850 CDK inhibitors Francis Xavier Tavares 2019-01-29
10189851 CDK inhibitors Francis Xavier Tavares 2019-01-29
10085992 Transient protection of normal cells during chemotherapy John Emerson Bisi, Patrick Joseph Roberts, Francis Xavier Tavares 2018-10-02
10076523 HSPC-sparing treatments for RB-positive abnormal cellular proliferation John Emerson Bisi, Patrick Joseph Roberts, Francis Xavier Tavares 2018-09-18
9957276 CDK inhibitors Francis Xavier Tavares 2018-05-01
9931345 Transient protection of normal cells during chemotherapy John Emerson Bisi, Patrick Joseph Roberts, Francis Xavier Tavares 2018-04-03
9808461 Protection of renal tissues from ischemia through inhibition of the proliferative kinases CDK4 and CDK6 Derek Dirocco, Norman E. Sharpless, John Emerson Bisi, Patrick Joseph Roberts, Benjamin D. Humphreys +1 more 2017-11-07
9717735 Tricyclic lactams for use in HSPC-sparing treatments for RB-positive abnormal cellular proliferation John Emerson Bisi, Patrick Joseph Roberts, Ricky D. Gaston, Robert C. Gadwood 2017-08-01
9527857 HSPC-sparing treatments for RB-positive abnormal cellular proliferation John Emerson Bisi, Patrick Joseph Roberts, Francis Xavier Tavares 2016-12-27
9499564 CDK inhibitors Francis Xavier Tavares 2016-11-22
9487530 Transient protection of normal cells during chemotherapy John Emerson Bisi, Patrick Joseph Roberts, Francis Xavier Tavares 2016-11-08
9481691 CDK inhibitors Francis Xavier Tavares 2016-11-01
9464092 Transient protection of normal cells during chemotherapy John Emerson Bisi, Patrick Joseph Roberts, Francis Xavier Tavares 2016-10-11
9102682 CDK inhibitors Francis Xavier Tavares 2015-08-11
8829012 CDK inhibitors Francis Xavier Tavares 2014-09-09
8822683 CDK inhibitors Francis Xavier Tavares 2014-09-02
8691830 CDK inhibitors Francis Xavier Tavares 2014-04-08
8598186 CDK inhibitors Francis Xavier Tavares 2013-12-03